Scientists Make Gains on 'Universal' Ebola Medicine

Scientists have created a single treatment that may fight the two deadliest strains of the Ebola virus. The current Ebola medicine now being tested in humans, called ZMapp, is only aimed at the Zaire Ebola strain, which is responsible for the most recent and deadliest outbreak. Sudan ebolavirus and the Zaire strain, called Zaire ebolavirus, together have been responsible for about 95 percent of Ebola deaths since the virus was first identified in 1976, according to CDC data.